A PHASE 1 STUDY TO EVALUATE THE BIOEQUIVALENCE OF ORAL TABLET AND ORALLY DISSOLVING TABLET FORMULATIONS OF RIMEGEPANT, A SMALL MOLECULE CGRP RECEPTOR ANTAGONIST

被引：0
|
作者：
Croop, R. [1 ]
Ivans, A. [1 ]
Stock, D. [1 ]
Hould, J. [1 ]
Morris, B. A. [1 ]
Stringfellow, J. [1 ]
Jensen, C. M. [1 ]
Moulin, J. -A. [2 ]
Larouche, R. [2 ]
Tanguay, M. [2 ]
Coric, V. [1 ]
Lipton, R. B. [3 ]
机构：
[1] Biohaven Pharmaceut, New Haven, CT USA
[2] Syneos Hlth, Quebec City, PQ, Canada
[3] Albert Einstein Coll Med, New York, NY USA
来源：
CEPHALALGIA | 2018年 / 38卷
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
MTIS2018-1
引用
收藏
页码：142 / 143
页数：2
相关论文
共 50 条
  • [31] Pharmacokinetics and Safety of Estradiol Valerate Tablet and Its Generic: A Phase 1 Bioequivalence Study in Healthy Chinese Postmenopausal Female Subjects
    Zhang, Li
    Li, Mupeng
    Fan, Lianlian
    Liu, Fangfang
    Zhang, Peiwen
    Huang, Qian
    Mai, Gang
    Shentu, Jianzhong
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2024, 18 : 2891 - 2904
  • [32] Efficacy of an ondansetron orally disintegrating tablet:: A novel oral formulation of this 5-HT3 receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis
    LeBourgeois, JP
    McKenna, CJ
    Coster, B
    Feyer, P
    Franzén, L
    Goedhals, L
    Marzecki, Z
    Souhami, L
    Stewart, A
    Tonnessen, F
    Haigh, C
    Mitchell, T
    Wilkinson, JR
    Graham, E
    CLINICAL ONCOLOGY, 1999, 11 (05) : 340 - 347
  • [33] Pharmacokinetic and Bioequivalence Comparison Between Orally Disintegrating and Conventional Tablet Formulations of Flurbiprofen: A Single-Dose, Randomized-Sequence, Open-Label, Two-Period Crossover Study in Healthy Chinese Male Volunteers
    Liu, Yan-Mei
    Liu, Gang-Yi
    Liu, Yun
    Li, Shui-Jun
    Jia, Jing-Ying
    Zhang, Meng-Qi
    Lu, Chuan
    Zhang, Yong-Mei
    Li, Xue-Ning
    Yu, Chen
    CLINICAL THERAPEUTICS, 2009, 31 (08) : 1787 - 1795
  • [34] Efficacy, Safety, and Tolerability of Rimegepant 75 Mg, an Oral CGRP Receptor Antagonist, for the Acute Treatment of Migraine: Results from a Double-blind, Randomized, Placebo-controlled Trial, Study 301
    Lipton, R. B.
    Conway, C. M.
    Stock, E. G.
    Stock, D.
    Morris, B. A.
    McCormack, T.
    Frost, M.
    Gentile, K.
    Coric, V
    Croop, R.
    HEADACHE, 2018, 58 (08): : 1336 - 1337
  • [35] Two-Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants
    Schueller, Olivier
    Regev, Galit
    Singh, Nand
    Willson, Ashley
    Beville, Mark
    Kanji, Nazim
    Lohmer, Lauren
    Patel, Jeegar
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (05): : 491 - 498
  • [36] A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15-mg Tylerdipine Tablet in Healthy Chinese Male Volunteers
    Wang, Lu
    Xie, Lijun
    Zhou, Sufeng
    Wang, Yuanyuan
    Chen, Juan
    Zhou, Yanli
    Liu, Yun
    Zhang, Hongwen
    Tao, Mingxue
    Ou, Ning
    Shao, Feng
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 126 - 132
  • [37] A PHASE 1 STUDY OF MP470, A NOVEL ORALLY BIOAVAILABLE SMALL MOLECULE WITH RAD 51 SUPPRESSION ACTIVITY
    Tibes, R.
    Berk, G.
    Fine, G. D.
    Choy, G. S.
    Tolcher, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 160 - 160
  • [38] Bioavailability and Pharmacokinetics of TRPV1 Antagonist Mavatrep (JNJ-39439335) Tablet and Capsule Formulations in Healthy Men: Two Open-Label, Crossover, Single-Dose Phase 1 Studies
    Manitpisitkul, Prasarn
    Shalayda, Kevin
    Russell, Lucille
    Sanga, Panna
    Williams, Yinka
    Solanki, Bhavna
    Caruso, Joseph
    Moyer, John A.
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (07): : 699 - 711
  • [39] STABILITY STUDY OF SOME WATER-SOLUBLE TABLET FORMULATIONS PREPARED WITH ACRYLIC RESINS AS BINDERS .1. THE RELIABILITY OF ACCELERATED STABILITY TESTING TO EVALUATE 2 ACRYLIC RESIN POLYMERS
    ALY, SAS
    PHARMAZEUTISCHE INDUSTRIE, 1989, 51 (06): : 690 - 693
  • [40] A Single-blind, Randomized, Single-dose, Two-sequence, Two-period, Crossover Study to Assess the Bioequivalence between Two Oral Tablet Formulations of Rivaroxaban 20 mg in Healthy Mexican Volunteers
    Genis-Najera, Luis
    Sanudo-Maury, Maria Elena
    Moquete, Trinifer
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 826 - 831
12345